Literature DB >> 21687046

Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy.

Albert Stuart Reece1.   

Abstract

Here the dramatic and rapid response of a 54-year-old obese hypertensive man with poorly controlled insulin-dependent diabetes with a 33 year history of high dose heroin use, a 1 year history of refractory ulceration of his hands, ankles and feet, treated coronary artery disease, and the metabolic syndrome, to implantation with long-acting naltrexone implants is presented. In particular his hyperlipidaemia, hyperglycaemia, proinflammatory state, evidence of hepatic and renal insufficiency, arterial stiffness, and extensive and chronic cutaneous ulceration all improved dramatically over just 13 weeks, in association with complete control of his heroin, benzodiazepine, tobacco and cannabis use. The metabolic and vascular benefits were all highly statistically significant. The case is the first to document dramatic and rapid metabolic, immune and vascular improvements in association with clinical naltrexone therapy and are consistent with its likely effects in restoring addiction-related stem cell and immunological deficits.

Entities:  

Year:  2009        PMID: 21687046      PMCID: PMC3027914          DOI: 10.1136/bcr.08.2008.0799

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  47 in total

1.  Low-dose naltrexone therapy improves active Crohn's disease.

Authors:  Jill P Smith; Heather Stock; Sandra Bingaman; David Mauger; Moshe Rogosnitzky; Ian S Zagon
Journal:  Am J Gastroenterol       Date:  2007-01-11       Impact factor: 10.864

2.  The concept of allostasis and allostatic load.

Authors:  Marian Joëls
Journal:  Eur J Pharmacol       Date:  2008-01-24       Impact factor: 4.432

Review 3.  Stem cell review series: aging of the skeletal muscle stem cell niche.

Authors:  Suchitra D Gopinath; Thomas A Rando
Journal:  Aging Cell       Date:  2008-06-28       Impact factor: 9.304

4.  Ensuring the safety of new medications and devices: are naltrexone implants safe?

Authors:  Alex D Wodak; Robert Ali; David Henry; Lloyd Sansom
Journal:  Med J Aust       Date:  2008-04-21       Impact factor: 7.738

5.  Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.

Authors:  Mingyi Wang; Jing Zhang; Gaia Spinetti; Li-Qun Jiang; Robert Monticone; Di Zhao; Linda Cheng; Melissa Krawczyk; Mark Talan; Gianfranco Pintus; Edward G Lakatta
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

6.  Human immunodeficiency virus 1 infection, cocaine, and coronary calcification.

Authors:  Shenghan Lai; Joao A C Lima; Hong Lai; David Vlahov; David Celentano; Wenjing Tong; John G Bartlett; Joseph Margolick; Elliot K Fishman
Journal:  Arch Intern Med       Date:  2005-03-28

7.  Patterns of symptom complaints in methadone maintenance patients.

Authors:  K R Dyer; J M White
Journal:  Addiction       Date:  1997-11       Impact factor: 6.526

8.  Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium.

Authors:  Ian S Zagon; Joseph W Sassani; Roland L Myers; Patricia J McLaughlin
Journal:  Brain Res Bull       Date:  2007-01-08       Impact factor: 4.077

9.  Methadone induces CCR5 and promotes AIDS virus infection.

Authors:  Shunji Suzuki; Maria P Carlos; Linda F Chuang; José V Torres; Roy H Doi; Ronald Y Chuang
Journal:  FEBS Lett       Date:  2002-05-22       Impact factor: 4.124

10.  Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.

Authors:  G K Hulse; D E Arnold-Reed; G O'Neil; C-T Chan; R C Hansson
Journal:  Addict Biol       Date:  2004-03       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.